For eight of the nation’s largest publicly traded companies—Ascend Wellness, Columbia Care, Cresco Labs, Curaleaf, Green Thumb Industries, TerrAscend, Trulieve and Verano—2023 has offered the opportunity to capitalize on emerging markets as well as anticipated opportunities in states like Florida, Pennsylvania and Ohio, where adult-use legalization could materialize in the not-so-distant future.
These eight MSOs combine to operate 775 cannabis retail facilities in the U.S., including 65 dispensaries they either opened or acquired so far in 2023 (as of July 12). Specifically, Florida has been a top target for expansion this year with no cap on the number of dispensaries that licensees can open to serve a medical cannabis patient base approaching 850,000. Maryland, which launched adult-use sales July 1, and Pennsylvania also have been top states for expansion.
